Company Filing History:
1 out of 3 
1 out of 1 Years Active: 2010
Title: The Innovative Contributions of Carine Chevrier
Introduction
Carine Chevrier is a prominent inventor based in Ramonchamp, France, known for her significant contributions to the field of pharmaceutical innovations. With a total of two patents to her name, she has developed groundbreaking compounds aimed at addressing specific medical challenges.
Latest Patents
Carine's recent patents include:
1. **Heterotricyclic Metalloprotease Inhibitors** - This invention focuses on azatriocyclic-containing pharmaceutical agents. It introduces a new class of compounds that inhibit metalloproteases (MMP-3, MMP-8, and MMP-13), showcasing enhanced potency and selectivity compared to existing inhibitors.
2. **Heterobicyclic Metalloprotease Inhibitors** - This patent revolves around azabicyclic-containing agents that similarly target metalloproteases. The novel compounds developed here also exhibit improved potency and selectivity against MMP-8, MMP-13, and MMP-3, advancing the possibilities in the treatment of related medical conditions.
Career Highlights
Carine Chevrier has made considerable strides in her career by partnering with esteemed organizations in the pharmaceutical industry. Notably, she has worked with Alantos Pharmaceuticals Holding, Inc. and Alantos Pharmaceutical Holdings, Inc., where her research and developments have laid the groundwork for potential future treatments.
Collaborations
Throughout her professional journey, Carine has collaborated with talented individuals such as Christian Gege and Matthias Schneider. These collaborations have played a vital role in enhancing her inventions and driving innovation within the pharmaceutical landscape.
Conclusion
Carine Chevrier continues to make significant contributions to pharmaceutical research and innovation. Her patented inventions in the field of metalloprotease inhibitors exemplify her dedication to improving healthcare outcomes through scientific advancement. With her ongoing commitment to research and collaboration, Chevrier is poised to drive further innovations in the industry.